All Cases

Inflammatory / Autoimmune

Defining a go-to-market strategy that redefines a pharma company’s approach to the public sector in Mexico

Loss of Exclusivity impact analysis

Developed a comprehensive understanding of referral flows for a Cell Therapy in development for Type 1 Diabetes to inform strategic commercial engagement planning at a mid-sized pharmaceutical company

Identification of stakeholder-specific value propositions for a mid-size pharma company launching a therapy for a Lupus

Evaluated the global strategic launch plan and tailored it to fit the needs of the local marketplace, maximizing the patient pool touched by commercialization efforts

Business development scan and prioritization of potential Rheumatology assets for acquisition or in-licensing